Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

preview_player
Показать описание
Aleksander Popel, PhD. – Quantitative Systems Pharmacology: applications to immuno-oncology
  1. U.S. Food and Drug Administration
Рекомендации по теме
Model Informed Drug 0:20:21

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:18:28

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:17:03

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:15:51

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:23:07

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:14:33

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:17:30

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:17:32

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:31:10

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:06:18

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:20:52

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:14:58

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:19:56

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:16:38

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:20:21

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Modeling informed drug 0:22:57

Modeling informed drug development

Model Informed Drug 0:21:27

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

Model Informed Drug 0:19:55

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

How Can Model 0:43:49

How Can Model Informed Drug Development Impact Your Program?

Strategic Implementation of 1:12:39

Strategic Implementation of Model-informed Drug Development (MIDD) for Regulatory Success

Value Focused MIDD: 0:03:13

Value Focused MIDD: Oncology Model-informed Drug Development Program

MIDD Training Module 0:51:00

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness...

Value Focused MIDD: 0:04:05

Value Focused MIDD: Respiratory Syncytial Virus (RSV) Model-informed Drug Development Program

Optimizing Drug Development 0:42:17

Optimizing Drug Development with Model-Informed Decision Making